Iovance Biotherapeutics Depreciation & Amortization 2011-2026 | IOVA

Annual Depreciation & Amortization Iovance Biotherapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
12.9 M	11.3 M	11.6 M	9.31 M	3.11 M	1.14 M	1.17 M	956 K	952 K	978 K	999 K	88.2 K	7.09 K	6.21 K	2.7 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
12.9 M	2.7 K	3.63 M

Quarterly Depreciation & Amortization Iovance Biotherapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
9.01 M	3.4 M	2.79 M	-	9.73 M	3 M	2.98 M	-	2.9 M	2.9 M	2.76 M	-	2.5 M	2.2 M	1.8 M	-	1.77 M	300 K	372 K	-	819 K	512 K	252 K	-	875 K	560 K	271 K	-	704 K	453 K	228 K	-	710 K	464 K	221 K	-	688 K	540 K	269 K	-	691 K	425 K	185 K	-	23 K	17.7 K	16.6 K	-	4.9 K	3.11 K	1.96 K	-	4.66 K	3.1 K	1.55 K	-	55.9 K	36.8 K	18.1 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
9.73 M	1.55 K	1.28 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Esperion Therapeutics ESPR	105 K	$ 3.13	0.55 %	$ 651 M	USA
Exelixis EXEL	29.1 M	$ 48.2	8.51 %	$ 13.1 B	USA
Fortress Biotech FBIO	403 K	$ 2.53	2.85 %	$ 70.6 M	USA
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Genprex GNPX	6.69 K	$ 0.91	2.24 %	$ 849 K	USA
Ionis Pharmaceuticals IONS	10 M	$ 77.0	2.33 %	$ 12.3 B	USA
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Kymera Therapeutics KYMR	8.31 M	$ 85.79	3.72 %	$ 7.25 B	USA
Ligand Pharmaceuticals Incorporated LGND	35.2 M	$ 231.58	-0.31 %	$ 4.24 B	USA
INmune Bio INMB	84 K	$ 1.54	-	$ 38.1 M	USA
Liquidia Corporation LQDA	1.53 M	$ 41.64	3.75 %	$ 3.58 B	USA
ACADIA Pharmaceuticals ACAD	920 K	$ 22.58	1.03 %	$ 3.74 B	USA
Mirum Pharmaceuticals MIRM	24.2 M	$ 107.36	1.46 %	$ 5.39 B	USA
MannKind Corporation MNKD	12.3 M	$ 3.61	26.17 %	$ 1.1 B	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.46	-1.14 %	$ 5.7 M	Israel
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 24.0	2.46 %	$ 3.05 B	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA